2008Zhejiang Medical JournalRequires access

Expression of COX-2 in uterine adenomyosis and its clinical significance

Wenshu Chen

Open publisher page 0 citations

Abstract

Objective To investigate the expression of Cyclooxygenase-2 (COX-2) in uterine adenomyosis and its clinical significance. Methods The expression of COX-2 was examined by immunohistochemistry SP method, in ectopic endometrium and eutopic endometrium of patients with uterine adenomyosis, the results were compared with normal endometrium. Results COX-2 expression in ectopic or eutopic endometrium with adenomyosis was significantly higher than that in normal endometrium. (P 0.05) . No statistically significant difference was found between ectopic endometrium and eutopic endometrium of adenomyosis(P0.05). And there were no significant differences in COX-2 expression between proliferative phase and secretive phase of endometrium. Conclusion High expression of COX-2 may be involved in the pathogenesis and development of uterine adenomyosis, which may provide potent target for treatment of adenomyosis.

About this research paper

What this paper is about

Objective To investigate the expression of Cyclooxygenase-2 (COX-2) in uterine adenomyosis and its clinical significance. Methods The expression of COX-2 was examined by immunohistochemistry SP method, in ectopic endometrium and eutopic endometrium of patients with uterine adenomyosis, the results were compared with normal endometrium. Results COX-2 expression in ectopic or eutopic endometrium with adenomyosis was significantly higher than that in normal endometrium. (P 0.05) . No statistically significant difference was found between ectopic endometrium and eutopic endometrium of adenomyosis(P0.05). And there were no significant differences in COX-2 expression between proliferative phase and secretive phase of endometrium. Conclusion High expression of COX-2 may be involved in the pathogenesis and development of uterine adenomyosis, which may provide potent target for treatment of adenomyosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the expression of Cyclooxygenase-2 (COX-2) in uterine adenomyosis and its clinical significance. Methods The expression of COX-2 was examined by immunohistochemistry SP method, in ectopic endometrium and eutopic endometrium of patients with uterine adenomyosis, the results were compared with normal endometrium. Results COX-2 expression in ectopic or eutopic endometrium with adenomyosis was significantly higher than that in normal endometrium. (P 0.05) . No statistically significant difference was found between ectopic endometrium and eutopic endometrium of adenomyosis(P0.05). And there were no significant differences in COX-2 expression between proliferative phase and secretive phase of endometrium. Conclusion High expression of COX-2 may be involved in the pathogenesis and development of uterine adenomyosis, which may provide potent target for treatment of adenomyosis.

Key concepts: Adenomyosis, Medicine, Endometrium, Immunohistochemistry, Pathogenesis, Gynecology, Clinical significance, Myometrium

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression of COX-2 in uterine adenomyosis and its clinical significance — Research Paper | ScholarLens